• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Shattuck Labs downgraded by H.C. Wainwright

    10/1/24 10:35:14 AM ET
    $STTK
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $STTK alert in real time by email
    H.C. Wainwright downgraded Shattuck Labs from Buy to Neutral
    Get the next $STTK alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $STTK

    DatePrice TargetRatingAnalyst
    3/17/2025$4.00Outperform
    Leerink Partners
    10/2/2024$8.00 → $2.00Buy → Neutral
    Citigroup
    10/2/2024Buy → Hold
    Needham
    10/1/2024Buy → Neutral
    H.C. Wainwright
    6/17/2024Buy → Neutral
    BTIG Research
    8/31/2022$12.00Buy
    BTIG Research
    6/1/2022$13.00Buy
    Citigroup
    5/2/2022$28.00Buy
    H.C. Wainwright
    More analyst ratings

    $STTK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Technical Officer Shukla Abhinav A. covered exercise/tax liability with 2,261 shares, decreasing direct ownership by 3% to 73,536 units (SEC Form 4)

      4 - Shattuck Labs, Inc. (0001680367) (Issuer)

      1/28/25 6:13:29 PM ET
      $STTK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Business Officer Deyoung Casi covered exercise/tax liability with 2,297 shares, decreasing direct ownership by 3% to 81,465 units (SEC Form 4)

      4 - Shattuck Labs, Inc. (0001680367) (Issuer)

      1/28/25 6:08:41 PM ET
      $STTK
      Biotechnology: Pharmaceutical Preparations
      Health Care
    • Chief Medical Officer Pandite Arundathy N. covered exercise/tax liability with 3,211 shares, decreasing direct ownership by 2% to 206,265 units (SEC Form 4)

      4 - Shattuck Labs, Inc. (0001680367) (Issuer)

      1/28/25 6:04:53 PM ET
      $STTK
      Biotechnology: Pharmaceutical Preparations
      Health Care